153 web-programmer-developer "https:" "https:" "https:" "https:" "https:" "https:" "University of Kent" positions at Ghent University in Belgium
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
to finetune the final research design of their case study to fit the broader project, and to develop their ethics and data management plan in line with Justice Vision’s broader ethical orientation
-
Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description → Apply until 12/01/2026 (DD/MM/YYYY) 23:59 (Brussels time) → Discipline
-
What? The focus of strategic basic research is on innovative research which, if successful, will create prospects for economic or societal applications. The SBO programme breaks down into two
-
, please contact: BOF@UGent.be For more information on the PhD admission procedure and joint PhDs at UGent, see the following web pages: Documents
-
Requirements The Odysseus programme is open to two types of candidates: Type I: Researchers who are internationally recognized as pioneers in their field and who have an appointment of minimum 80
-
million EUR project funded by the European Research Council (ERC), which started in September 2023. The goal is to develop the next generation of fire testing. Current fire testing is based on standardized
-
/C++ is a must. Knowledge of and experience with any of the following are highly relevant: knowledge of the principles underlying C/C++/Rust developer tools (e.g., debuggers, compilers, software
-
joint degree or double/multiple degrees. The joint study programme should lead to new jointly developed programme-level learning outcomes, but can be based on existing and/or newly developed course offer
-
Partnership with the Joint Research Centre of the European Commission will focus on further development of innovative health biotechnological drugs, more specifically mRNA therapeutics. As the science and
-
- Doctoral fellow. JOB PROFILE This Collaborative Doctoral Partnership with the Joint Research Centre of the European Commission will focus on further development of innovative health biotechnological drugs